RSI Oversold Bounce Stocks — Overview View · Biological Products, (No Diagnostic Substances)
5 stocks match the RSI Oversold Bounce Stocks screen. Stocks whose 14-day RSI has just crossed back above 30 out of oversold territory — a potential reversal. Overview columns. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–5 of 5
| GLUE | Monte Rosa Therapeutics, Inc. | Healthcare | Biological Products, (No Diagnostic Substances) | $1.2B | -7.62 | 14.39 | +1.12% | Sell | 38K |
| GRML | Greenland Mines Ltd | Healthcare | Biological Products, (No Diagnostic Substances) | $715M | -32.84 | 4.50 | -7.31% | Sell | 22K |
| SCLX | Scilex Holding Co | Healthcare | Biological Products, (No Diagnostic Substances) | $45M | -0.10 | 5.31 | -0.56% | Sell | 2K |
| PMCB | PharmaCyte Biotech, Inc. | Healthcare | Biological Products, (No Diagnostic Substances) | $5M | -0.33 | 0.49 | +1.62% | Sell | 800 |
| VIVS | VivoSim Labs, INC. | Healthcare | Biological Products, (No Diagnostic Substances) | $4M | -0.30 | 0.28 | -1.01% | Sell | 8K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.